Now showing items 1-10 of 10
Lessons from the past : historical perspectives of mental health in the Eastern Cape
(AOSIS Publishing, 2014-07-30)
The development of mental health services in the Eastern Cape Province is inextricably entwined in South Africa’s colonial history and the racist policy of apartheid. Prior to the development of mental hospitals, mental ...
Staff and bed distribution in public sector mental health services in the Eastern Cape Province, South Africa
(AOSIS Publishing, 2014-11)
Background. The Eastern Cape Province of South Africa is a resource-limited province with a fragmented mental health service. Objective. To determine the current context of public sector mental health services in terms ...
Instruments measuring blunted affect in schizophrenia : a systematic review
(Public Library of Science, 2015-06)
Blunted affect, also referred to as emotional blunting, is a prominent symptom of schizophrenia. Patients with blunted affect have difficulty in expressing their emotions. The work of Abrams and Taylor and their development ...
Forensic mental health services: Current service provision and planning for a prison mental health service in the Eastern Cape
(AOSIS Publishing, 2016)
Objectives: No research data exists on forensic psychiatric service provision in the Eastern Cape, Republic of South Africa. The objective of this research was to assess current forensic psychiatric service provision and ...
Alcohol and brain damage
[No abstract available]
Studies in the psychopathology, neurobiology and psychopharmacology of schizophrenia
(Stellenbosch : Stellenbosch University, 2008-03)
ENGLISH ABSTRACT: The overall aim of these studies was to investigate selected aspects of psychopathology, neurobiological abnormalities and treatment in schizophrenia. The following topics were researched: 1. ...
Placebo controls in clinical trials : concerns about use in relapse prevention studies in schizophrenia
(BMJ Publishing Group, 2016)
ENGLISH SUMMARY : The use of placebos in clinical trials has major policy implications for ethical conduct across all of medicine and is relevant to clinicians, patients, drug development, and regulatory agencies. This ...
The nature of relapse in schizophrenia
(BioMed Cenral, 2013-02)
Background Multiple relapses characterise the course of illness in most patients with schizophrenia, yet the nature of these episodes has not been extensively researched and clinicians may not always be aware of important ...
Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
(Dove Medical Press, 2017)
Background: Long-acting antipsychotic therapy may be best suited for patients in the early stage of schizophrenia, when the most can be done before disease progression associated with poor adherence occurs. We explored the ...
Cognitive-perceptual deficits and symptom correlates in first-episode schizophrenia
(AOSIS Publishing, 2017)
Background: Thought disorder and visual-perceptual deficits have been well documented, but their relationships with clinical symptoms and cognitive function remain unclear. Cognitive-perceptual deficits may underscore ...